Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Concise Review: Innate and Adaptive Immune Recognition of Allogeneic and Xenogeneic Cell Transplants in the Central Nervous System
Chloé Hoornaert, Debbie Le Blon, Alessandra Quarta, et al.
Stem Cells Translational Medicine (2017) Vol. 6, Iss. 5, pp. 1434-1441
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The potential of hyaluronic acid in immunoprotection and immunomodulation: Chemistry, processing and function
Fernanda Zamboni, Sílvia Vieira, Rui L. Reis, et al.
Progress in Materials Science (2018) Vol. 97, pp. 97-122
Open Access | Times Cited: 177
Stem cell therapy for neurological disorders
Marco Alessandrini, Olivier Preynat‐Seauve, K De Briun, et al.
South African Medical Journal (2019) Vol. 109, Iss. 8b, pp. 70-70
Open Access | Times Cited: 118
The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury
Christopher S. Ahuja, Andrea J. Mothe, Mohammad Rasool Khazaei, et al.
Stem Cells Translational Medicine (2020) Vol. 9, Iss. 12, pp. 1509-1530
Open Access | Times Cited: 109
Conditioned medium-electrospun fiber biomaterials for skin regeneration
Lu Chen, Liying Cheng, Zhen Wang, et al.
Bioactive Materials (2020) Vol. 6, Iss. 2, pp. 361-374
Open Access | Times Cited: 55
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies
Jessica Rosati, Daniela Ferrari, Filomena Altieri, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 10
Open Access | Times Cited: 45
Assessment of immune modulation strategies to enhance survival and integration of human neural progenitor cells in rodent models of spinal cord injury
Zijian Lou, Antonia Post, Narihito Nagoshi, et al.
Stem Cells Translational Medicine (2025) Vol. 14, Iss. 2
Open Access
In Situ Synthesized Silver Nanoclusters for Tracking the Role of Telomerase Activity in the Differentiation of Mesenchymal Stem Cells to Neural Stem Cells
Fangyuan Dong, Enduo Feng, Tingting Zheng, et al.
ACS Applied Materials & Interfaces (2017) Vol. 10, Iss. 2, pp. 2051-2057
Closed Access | Times Cited: 34
A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain
Jung Won Hwang, Na Kyung Lee, Je Hoon Yang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3052-3052
Open Access | Times Cited: 32
Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?
Cristina Salado-Manzano, Unai Perpiñá, Marco Straccia, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 28
Single‐Cell Microgels for Diagnostics and Therapeutics
Ryan Dubay, Joseph N. Urban, Eric M. Darling
Advanced Functional Materials (2021) Vol. 31, Iss. 44
Open Access | Times Cited: 24
Current knowledge and challenges associated with targeted delivery of neurotrophic factors into the central nervous system: focus on available approaches
Gozal Bahlakeh, Reza Rahbarghazi‬, Daruosh Mohammadnejad, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 23
The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype
Urszula Kozłowska, Aleksandra Klimczak, Kalina Wiatr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19
Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas
María Norte‐Muñoz, Alejandro Gallego‐Ortega, Fernando Lucas‐Ruiz, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment
Daniela Ferrari, Maurizio Gelati, Daniela Celeste Profico, et al.
Results and problems in cell differentiation (2018), pp. 307-329
Closed Access | Times Cited: 22
Drug-like delivery methods of stem cells as biologics for stroke
Julian P. Tuazon, Vanessa Castelli, Cesar V. Borlongan
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 8, pp. 823-833
Open Access | Times Cited: 20
Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain
Lucas Schirmer, Chloé Hoornaert, Debbie Le Blon, et al.
Biomaterials Science (2020) Vol. 8, Iss. 18, pp. 4997-5004
Open Access | Times Cited: 18
Cell therapy for Parkinson′s disease is coming of age: current challenges and future prospects with a focus on immunomodulation
Shirley D. Wenker, Fernando J. Pitossi
Gene Therapy (2019) Vol. 27, Iss. 1-2, pp. 6-14
Closed Access | Times Cited: 17
Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma
Jung Won Hwang, Su Hyeon Myeong, Na-Hee Lee, et al.
Cell Transplantation (2021) Vol. 30
Open Access | Times Cited: 13
Clinical considerations in Parkinson’s disease cell therapy
Jun Xue, Yifan Wu, Yuting Bao, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101792-101792
Closed Access | Times Cited: 9
Severe-combined immunodeficient rats can be used to generate a model of perinatal hypoxic-ischemic brain injury to facilitate studies of engrafted human neural stem cells
Stephanie R. Beldick, James Hong, Svetlana M. Altamentova, et al.
PLoS ONE (2018) Vol. 13, Iss. 11, pp. e0208105-e0208105
Open Access | Times Cited: 16
Monoclonal antibody‐mediated immunosuppression enables long‐term survival of transplanted human neural stem cells in mouse brain
Lisa M. McGinley, Kevin S. Chen, Shayna N. Mason, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 8
Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
Ainsley Mike Antao, Janardhan Keshav Karapurkar, Dong Ryul Lee, et al.
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 3649-3665
Open Access | Times Cited: 12
Microglia-secreted TNF-α affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors
Shirley D. Wenker, María Isabel Farías, Victoria Gradaschi, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0263021-e0263021
Open Access | Times Cited: 4
Various detailed characteristics of a new enhanced neurotrophic factor secreting rat derived bone marrow mesenchymal stem cells and its preliminary application in rat models of ischemic stroke
Fenjun Jiang, Hui Zhou, Yanwen Cheng, et al.
Experimental Cell Research (2022) Vol. 416, Iss. 1, pp. 113140-113140
Open Access | Times Cited: 7
Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles
Dan Wei, Jiali Hou, Keren Zheng, et al.
Current Gene Therapy (2019) Vol. 19, Iss. 5, pp. 330-341
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top